Genome wide screening of G-quadruplex forming sequences under molecular crowding environment.
Endoh, T., Okuda, S., Ling, Y., Tateishi, H., Sugimoto, N. Genome wide screening of G-quadruplex forming sequences under molecular crowding environment. S−FISNA2024, Japan (2024/3/1).
Generation of Amino Acid Sequences of Unknown Species for Metaproteomics Using Phylogenetic Relationships of Known Species.
Miura, N., Tabata, T., Ishihama, Y., Okuda, S. Generation of Amino Acid Sequences of Unknown Species for Metaproteomics Using Phylogenetic Relationships of Known Species. HUPO2023, Busan (2023/9/19).
A biomarker study of atezolizumab (atezo) + bevacizumab (bev) + carboplatin (carbo) + paclitaxel (pac) (ABCP) for patients with NSCLC harboring EGFR mutations (EGFRm) after failure of TKI therapy: NEJ043.
Watanabe, S., Furuya, N., Nakamura, A., Shiihara, J., Nakachi, I., Tanaka, H., Nakao, M., Minato, K., Seike, M., Sasaki, S., Kisohara, A., Takeuchi, S., Honda, R., Takamura, K., Ling, Y., Okuda, S., Kagamu, H., Yoshimura, K., Kikuchi, T., Kobayashi, K. A biomarker study of atezolizumab (atezo) + bevacizumab (bev) + carboplatin (carbo) + paclitaxel (pac) (ABCP) for patients with NSCLC harboring EGFR mutations (EGFRm) after failure of TKI therapy: NEJ043. ASCO annual meeting 2023, Chicago (2023/6/4).
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Nagahashi, M., Ling, Y., Toshikawa, C., Hayashida, T., Kitagawa, Y., Futamura, M., Kuwayama, T., Nakamura, S., Yamauchi, H., Yamauchi, T., Kaneko, K., Kanbayashi, C., Sato, N., Tsuchida, J., Moro, K., Nakajima, M., Shimada, Y., Ichikawa, H., Lyle, S., Miyoshi, Y., Takabe, K., Okuda, S., Wakai, T. Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients. SABCS2022, San Antonio (2022/12/6).
A Novel Approach to Construct Variant Protein Sequences for Precision Medical Proteogenomics.
Yiwei, Ling., Okuda, S. A Novel Approach to Construct Variant Protein Sequences for Precision Medical Proteogenomics. HUPO2022, Cancun (2022/12/5).
New method to construct a reference amino acid sequence database for metaproteome analysis.
Miura, N., Ishihama, Y., Okuda, S. New method to construct a reference amino acid sequence database for metaproteome analysis. HUPO2021, Stockholm/Hybrid (2021/11/18).
Construction of amino acid sequence database for metaproteome analysis using genomes of closely related species.
Miura, N., Ishihama, Y., Okuda, S. Construction of amino acid sequence database for metaproteome analysis using genomes of closely related species. ASMS2021, Philadelphia/Hybrid (2021/10/31).
The GlyCosmos portal as a partner in the GlySpace Alliance to provide access to integrated glycan-related data resources.
Yamada, I., Shiota, M., Shinmachi, D., Ono, T., Tsuchiya, S., Matsubara, M., Hosoda, M., Fujita, A., Aoki, N. P., Watanabe, Y., Fujita, N., Angata, K., Kaji, H., Narimatsu, H., Okuda, S., Aoki-Kinoshita, K. F. The GlyCosmos portal as a partner in the GlySpace Alliance to provide access to integrated glycan-related data resources. SFG2020, Virtual (2020/11/10).
Mutational signatures and clinicopathological relationship extracted from clinical sequence data of 201 caseswith colorectal cancer.
Takeuchi, S., Ling, Y., Watanabe, Y., Shimada, Y., Wakai, T., Okuda, S. Mutational signatures and clinicopathological relationship extracted from clinical sequence data of 201 caseswith colorectal cancer. ASHG2019, Houston (2019/10/16).
Network analysis of proteogenomics data in lung cancer cell lines.
Watanabe, Y., Ling, Y., Uemura, H., Yoshizawa, A. C., Ishihama, Y., Okuda, S. Network analysis of proteogenomics data in lung cancer cell lines. HUPO2019, Adelaide (2019/9/17).